Log In
Print
BCIQ
Print
Print this Print this
 

10% human immune globulin (Bivigam)

  Manage Alerts
Collapse Summary General Information
Company Biotest AG
DescriptionPolyspecific IV immune globulin
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationPrimary immunodeficiency disease (PIDD)
Indication DetailsTreat primary immune deficiency disorders
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today